Competitive Landscape by Indication
Data updated: Nov 12, 2026
160 indications, 120,230 trials mapped
Oncology
56,582 trialsSolid Tumor (Advanced)
9843 trials
901 Ph3
Merck, Sichuan Baili Pharmaceutical Co., Ltd., GSK
Breast Cancer
4059 trials
725 Ph3
AstraZeneca, Roche, Pfizer
Non-Hodgkin Lymphoma
4010 trials
362 Ph3
Merck, Roche, AstraZeneca
NSCLC
3537 trials
578 Ph3
AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.
Colorectal Cancer
2692 trials
381 Ph3
AbbVie, AstraZeneca, Revolution Medicines, Inc.
Prostate Cancer
2357 trials
361 Ph3
Novartis, AstraZeneca, Jiangsu HengRui Medicine Co., Ltd.
Multiple Myeloma
1977 trials
245 Ph3
Johnson & Johnson, GSK, AbbVie
AML
1854 trials
177 Ph3
AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.
Hematologic Malignancies
1749 trials
154 Ph3
Johnson & Johnson, Novartis, Merck
Melanoma
1690 trials
143 Ph3
Bristol-Myers Squibb, Merck, Regeneron
Pancreatic Cancer
1641 trials
142 Ph3
Revolution Medicines, Inc., Astellas, AstraZeneca
Hepatocellular Carcinoma
1461 trials
224 Ph3
AstraZeneca, Akeso, Roche
Ovarian Cancer
1425 trials
171 Ph3
AstraZeneca, AbbVie, Merck
Lung Cancer (General)
1348 trials
173 Ph3
Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.
Head and Neck Cancer
1286 trials
117 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Genmab
MDS
1207 trials
100 Ph3
Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.
Gastric Cancer
1134 trials
186 Ph3
AstraZeneca, Astellas, Chongqing Precision Biotech Co., Ltd
Sarcoma
1075 trials
75 Ph3
USWM CT, LLC, Eli Lilly, Novartis
Bladder Cancer
1018 trials
145 Ph3
Merck, AstraZeneca, Pfizer
Glioblastoma
997 trials
66 Ph3
Novartis, GT Medical Technologies, Inc., Philogen S.p.A.
ALL
961 trials
94 Ph3
Novartis, Amgen, Chongqing Precision Biotech Co., Ltd
Esophageal Cancer
824 trials
135 Ph3
AstraZeneca, Merck, Pfizer
Brain Tumor
809 trials
58 Ph3
Nuvation Bio Inc., InSightec, Jazz Pharmaceuticals
Renal Cell Carcinoma
800 trials
74 Ph3
Merck, Exelixis, Bristol-Myers Squibb
CLL
792 trials
84 Ph3
BeOne Medicines, Acerta Pharma BV, AbbVie
Squamous Cell Carcinoma
675 trials
68 Ph3
Regeneron, Merck, AstraZeneca
Cholangiocarcinoma
621 trials
64 Ph3
AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly
Triple Negative Breast Cancer
619 trials
72 Ph3
Gilead, Novartis, AstraZeneca
SCLC
585 trials
78 Ph3
Amgen, Boehringer Ingelheim, Merck
Cervical Cancer
539 trials
90 Ph3
AstraZeneca, Merck, Shanghai Bovax Biotechnology Co., Ltd.
Hodgkin Lymphoma
488 trials
37 Ph3
Merck, Takeda, Tessa Therapeutics
Endometrial Cancer
480 trials
52 Ph3
AstraZeneca, Merck, Genmab
CML
407 trials
46 Ph3
Novartis, Shenzhen TargetRx Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Neuroendocrine Tumors
331 trials
43 Ph3
Advanced Accelerator Applications, Crinetics Pharmaceuticals Inc., Merck
Myelofibrosis
288 trials
35 Ph3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Novartis, Bristol-Myers Squibb
Mesothelioma
286 trials
18 Ph3
Novartis, AstraZeneca, Vivace Therapeutics, Inc
Thyroid Cancer
237 trials
36 Ph3
Exelixis, Eli Lilly, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HER2+ Breast Cancer
197 trials
35 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., Roche, Jazz Pharmaceuticals
HER2- Breast Cancer
181 trials
20 Ph3
AstraZeneca, Novartis, BeOne Medicines
Merkel Cell Carcinoma
102 trials
6 Ph3
TuHURA Biosciences, Inc., ImmunityBio, Inc., Novartis
CNS
10,666 trialsMajor Depression
1804 trials
484 Ph3
Neurocrine Biosciences, Johnson & Johnson, Xenon Pharmaceuticals Inc.
Alzheimer's Disease
1558 trials
297 Ph3
Eli Lilly, Bristol-Myers Squibb, Roche
Schizophrenia
959 trials
259 Ph3
Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb
Parkinson's Disease
954 trials
176 Ph3
iRegene Therapeutics Co., Ltd., Roche, Luye Pharma Group Ltd.
Multiple Sclerosis
876 trials
235 Ph3
Roche, Novartis, Sanofi
Migraine
528 trials
200 Ph3
Pfizer, AbbVie, H. Lundbeck A/S
Anxiety
479 trials
111 Ph3
Intra-Cellular Therapies, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc., Beijing Union Pharmaceutical Factory Ltd
Epilepsy
478 trials
171 Ph3
Praxis Precision Medicines, Rapport Therapeutics Inc., Biohaven Therapeutics Ltd.
Alcohol Use Disorder
453 trials
73 Ph3
Eli Lilly, Pop Test Oncology LLC, Newleos Therapeutics, Inc.
Opioid Use Disorder
434 trials
92 Ph3
Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Eli Lilly
ALS
360 trials
72 Ph3
Eli Lilly, Biogen, Amylyx Pharmaceuticals Inc.
Autism Spectrum Disorder
342 trials
66 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Curemark
ADHD
342 trials
122 Ph3
Otsuka Pharmaceutical Co., Ltd., Axsome Therapeutics, Inc., Bazelet Nehushtan LtD.
PTSD
327 trials
65 Ph3
Oui Therapeutics, Inc., COMPASS Pathways, Senseye, Inc.
Bipolar Disorder
293 trials
96 Ph3
Bristol-Myers Squibb, Intra-Cellular Therapies, Inc., Xenon Pharmaceuticals Inc.
Neuropathy
289 trials
71 Ph3
argenx, WinSanTor, Inc, Rinri Therapeutics
Huntington's Disease
106 trials
18 Ph3
Roche, Skyhawk Therapeutics, Inc., Novartis
OCD
84 trials
11 Ph3
Vericel Corporation, Biohaven Pharmaceuticals, Inc., Roche
Infectious Disease
10,142 trialsHIV
2317 trials
454 Ph3
Gilead, ViiV Healthcare, Merck
COVID-19
2273 trials
748 Ph3
ModernaTX, Inc., Pfizer, Invivyd, Inc.
Influenza
1193 trials
338 Ph3
GSK, ModernaTX, Inc., Valenta Pharm JSC
Hepatitis C
1018 trials
295 Ph3
Atea Pharmaceuticals, Inc., Gilead, Merck
Hepatitis B
650 trials
112 Ph3
Ausper Biopharma Co., Ltd., GSK, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Malaria
611 trials
131 Ph3
GSK, Sanaria Inc., Novartis
Sepsis
499 trials
166 Ph3
ImmunityBio, Inc., AstraZeneca, Bayer
Tuberculosis
491 trials
120 Ph3
Shanghai Jiatan Pharmatech Co., Ltd, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., GSK
RSV
302 trials
76 Ph3
GSK, Pfizer, Sanofi
Fungal Infections
225 trials
69 Ph3
Merck, Basilea Pharmaceutica, Mundipharma Research Limited
H. pylori
213 trials
50 Ph3
ARJ Medical, Inc., Onconic Therapeutics Inc., Catalysis SL
C. difficile
176 trials
45 Ph3
AstraZeneca, Vedanta Biosciences, Inc., Acurx Pharmaceuticals Inc.
Bacterial Infections
174 trials
35 Ph3
Pfizer, CanSino Biologics Inc., Grifols Therapeutics LLC
Metabolic
9,230 trialsType 2 Diabetes
2791 trials
854 Ph3
Eli Lilly, Novo Nordisk, AstraZeneca
Obesity
1893 trials
441 Ph3
Novo Nordisk, Eli Lilly, Pfizer
Diabetes (General)
1637 trials
412 Ph3
Gan & Lee Pharmaceuticals., Novo Nordisk, Eli Lilly
Type 1 Diabetes
828 trials
184 Ph3
Eli Lilly, Sanofi, Novo Nordisk
Dyslipidemia
744 trials
282 Ph3
Addpharma Inc., Qilu Pharmaceutical Co., Ltd., Merck
NASH/NAFLD
693 trials
111 Ph3
GSK, Madrigal Pharmaceuticals, Inc., Akero Therapeutics, Inc
Diabetic Complications
644 trials
146 Ph3
Roche, AbbVie, Regeneron
Cardiovascular
7,178 trialsHypertension
2212 trials
648 Ph3
Merck, Boryung Pharmaceutical Co., Ltd, Addpharma Inc.
Heart Failure
1224 trials
290 Ph3
Novo Nordisk, HELP Therapeutics Co., Ltd., Tasly Pharmaceutical Group Co., Ltd
Stroke
1212 trials
416 Ph3
Lumosa Therapeutics Co., Ltd., Beijing Suncadia Pharmaceuticals Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Coronary Artery Disease
1092 trials
240 Ph3
Novartis, XyloCor Therapeutics, Inc., Bayer
Atrial Fibrillation
510 trials
153 Ph3
Regeneron, Novartis, Anthos Therapeutics, Inc.
Myocardial Infarction
497 trials
142 Ph3
Novo Nordisk, Beijing Sungen Biomedical Technology Co., Ltd, Beijing Northland Biotech. Co., Ltd.
Thrombosis
286 trials
122 Ph3
Regeneron, Boston Scientific Corporation, Supergene, LLC
Arrhythmia
85 trials
29 Ph3
Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals
Hypertrophic Cardiomyopathy
60 trials
19 Ph3
Cytokinetics, Shandong Suncadia Medicine Co., Ltd., Bristol-Myers Squibb
Immunology
6,052 trialsRheumatoid Arthritis
1106 trials
293 Ph3
Bristol-Myers Squibb, AstraZeneca, AbbVie
Psoriasis
1057 trials
336 Ph3
Johnson & Johnson, Bristol-Myers Squibb, Hansoh BioMedical R&D Company
Atopic Dermatitis
857 trials
220 Ph3
Pfizer, AbbVie, Keymed Biosciences Co.Ltd
Lupus
572 trials
85 Ph3
AstraZeneca, Novartis, Bristol-Myers Squibb
Ulcerative Colitis
554 trials
133 Ph3
Takeda, AbbVie, Roche
Crohn's Disease
546 trials
152 Ph3
Takeda, Johnson & Johnson, AbbVie
Psoriatic Arthritis
192 trials
83 Ph3
UCB Biopharma SRL, AbbVie, Bristol-Myers Squibb
Lupus Nephritis
152 trials
29 Ph3
Novartis, Roche, China Immunotech (Beijing) Biotechnology Co., Ltd.
Sjogren's Disease
147 trials
23 Ph3
Bristol-Myers Squibb, Novartis, Amgen
IgA Nephropathy
146 trials
45 Ph3
Novartis, Otsuka Pharmaceutical Development & Commercialization, Inc., Vera Therapeutics, Inc.
Ankylosing Spondylitis
145 trials
46 Ph3
Bayer, Jiangsu vcare pharmaceutical technology co., LTD, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Myasthenia Gravis
142 trials
68 Ph3
argenx, UCB Biopharma SRL, AstraZeneca
Hidradenitis Suppurativa
139 trials
32 Ph3
Incyte Corporation, Novartis, AbbVie
IBD
113 trials
25 Ph3
Disc Medicine, Inc, iCell Gene Therapeutics, Parvus Therapeutics, Inc.
Chronic Spontaneous Urticaria
110 trials
42 Ph3
Novartis, Celldex Therapeutics, Hangzhou Highlightll Pharmaceutical Co., Ltd
NMOSD
74 trials
23 Ph3
AstraZeneca, Amgen, Roche
Pain
4,662 trialsAcute Pain
2872 trials
788 Ph3
Eli Lilly, Grünenthal GmbH, AFT Pharmaceuticals, Ltd.
Postoperative Pain
1157 trials
241 Ph3
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Shanghai Huilun Pharmaceutical Co., Ltd., Pacira Pharmaceuticals, Inc
Neuropathic Pain
329 trials
57 Ph3
Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.
Chronic Pain
304 trials
75 Ph3
Eli Lilly, Evon Medics LLC, iN Therapeutics Co., Ltd.
Respiratory
4,538 trialsAsthma
1454 trials
394 Ph3
GSK, AstraZeneca, Inmunotek S.L.
COPD
1215 trials
361 Ph3
GSK, AstraZeneca, Haisco Pharmaceutical Group Co., Ltd.
Pneumonia
532 trials
189 Ph3
GSK, Qilu Pharmaceutical Co., Ltd., Biotest
Cystic Fibrosis
486 trials
132 Ph3
Vertex Pharmaceuticals Incorporated, Boehringer Ingelheim, Arcturus Therapeutics, Inc.
Allergic Rhinitis
380 trials
144 Ph3
Inmunotek S.L., Genrix (Shanghai) Biopharmaceutical Co., Ltd., EMS
Idiopathic Pulmonary Fibrosis
317 trials
58 Ph3
Haisco Pharmaceutical Group Co., Ltd., Boehringer Ingelheim, Bristol-Myers Squibb
Chronic Rhinosinusitis with Nasal Polyps
154 trials
60 Ph3
Sanofi, GSK, Keymed Biosciences Co.Ltd
Musculoskeletal
1,791 trialsOsteoarthritis
1075 trials
288 Ph3
Eli Lilly, Pacira Pharmaceuticals, Inc, VivaTech International, Inc.
Osteoporosis
382 trials
102 Ph3
Amgen, Shenzhen Salubris Pharmaceuticals Co., Ltd., Qilu Pharmaceutical Co., Ltd.
Gout
236 trials
53 Ph3
Crystalys Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Innovent Biologics (Suzhou) Co. Ltd.
Muscle Spasm
98 trials
46 Ph3
Chongqing Claruvis Pharmaceutical Co., Ltd., Ipsen, Merz Pharmaceuticals GmbH
Ophthalmology
1,595 trialsAge-Related Macular Degeneration
565 trials
136 Ph3
Roche, AbbVie, Adverum Biotechnologies, Inc.
Glaucoma
533 trials
148 Ph3
Glaukos Corporation, SpyGlass Pharma, Inc., AbbVie
Dry Eye
497 trials
138 Ph3
Bausch & Lomb Incorporated, Laboratorios Sophia S.A de C.V., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Gastrointestinal
1,456 trialsNausea/Vomiting
402 trials
123 Ph3
Helsinn Healthcare SA, Fujian Shengdi Pharmaceutical Co., Ltd., Qilu Pharmaceutical (Hainan) Co., Ltd.
Peptic Ulcer
375 trials
99 Ph3
Tiger Biosciences, LLC., Applied Biologics, LLC, MediWound Ltd
Constipation
296 trials
110 Ph3
Ardelyx, Bausch Health Americas, Inc., Shionogi
Diarrhea
230 trials
66 Ph3
Bausch Health Americas, Inc., Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd
GERD
153 trials
47 Ph3
Onconic Therapeutics Inc., Cinclus Pharma Holding AB, Phathom Pharmaceuticals, Inc.
Rare Disease
1,427 trialsImmune Thrombocytopenia
379 trials
113 Ph3
Novartis, argenx, Amgen
Sickle Cell Disease
373 trials
71 Ph3
Novartis, Agios Pharmaceuticals, Inc., Forma Therapeutics, Inc.
Hemophilia
294 trials
131 Ph3
Roche, Pfizer, Suzhou Alphamab Co., Ltd.
Duchenne Muscular Dystrophy
170 trials
36 Ph3
Sarepta Therapeutics, Inc., NS Pharma, Inc., Italfarmaco
Spinal Muscular Atrophy
62 trials
23 Ph3
GeneCradle Inc, Biogen, Novartis
Fabry Disease
62 trials
29 Ph3
Amicus Therapeutics, Chiesi Farmaceutici S.p.A., Sanofi
Gaucher Disease
54 trials
20 Ph3
Spur Therapeutics, Prevail Therapeutics, Azafaros B.V.
Mastocytosis
28 trials
5 Ph3
Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics
CDKL5 Deficiency Disorder
5 trials
3 Ph3
Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals
Women's Health
1,112 trialsInfertility
495 trials
170 Ph3
Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas, Prokrea BCN, S.L.
PCOS
209 trials
61 Ph3
Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., Dexa Medica Group
Menopause
189 trials
51 Ph3
Astellas, Bayer, AbCellera Biologics Inc.
Endometriosis
171 trials
44 Ph3
AbbVie, Kissei Pharmaceutical Co., Ltd., Hope Medicine (Nanjing) Co., Ltd
Contraception
48 trials
13 Ph3
YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences
Renal
1,095 trialsDermatology
970 trialsAcne
395 trials
115 Ph3
Sanofi, Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd., Sagimet Biosciences Inc.
Alopecia
265 trials
67 Ph3
Pfizer, Veradermics, Inc., AbbVie
Rosacea
126 trials
39 Ph3
Tarsus Pharmaceuticals, Inc., Novartis, Galderma R&D
Vitiligo
124 trials
38 Ph3
Incyte Corporation, Pfizer, AbbVie
Skin Infections
60 trials
17 Ph3
GSK, Melinta Therapeutics, Inc., Durata Therapeutics Inc., an affiliate of Allergan plc
Urology
678 trialsOveractive Bladder
260 trials
67 Ph3
Vensica Therapeutics Ltd., Trigone Pharma Ltd., NinaMED Pty Ltd
Erectile Dysfunction
189 trials
56 Ph3
Aspargo Labs, Inc, EMS, Hanmi Pharmaceutical Company Limited
Benign Prostatic Hyperplasia
155 trials
48 Ph3
Addpharma Inc., Resurge Therapeutics Inc., Shanghai Huilun Pharmaceutical Co., Ltd.
Stress Urinary Incontinence
74 trials
28 Ph3
Levee Medical, Inc., Cook MyoSite, TBF Genie Tissulaire
Hepatology
447 trialsSleep
353 trialsEndocrine
256 trialsGrowth Hormone Deficiency
97 trials
35 Ph3
Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Xiamen Amoytop Biotech Co., Ltd.
Acromegaly
54 trials
18 Ph3
Marea Therapeutics, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Debiopharm International SA
Hypothyroidism
45 trials
11 Ph3
Neuvosyn Laboratories, LLC, AbbVie, IBSA Institut Biochimique SA
Adrenal Insufficiency
31 trials
6 Ph3
Neurocrine UK Limited
Hyperthyroidism
29 trials
8 Ph3
Biohaven Therapeutics Ltd., argenx, Merida Biosciences
Click any indication to see full competitive landscape (all sponsors, trials, phases).
Data: ClinicalTrials.gov | Mapping: Indication Taxonomy